Jay Vornhagen is 2017 graduate of the Pathobiology PhD program at the University of Washington Department of Global Health. He is currently completing a postdoc with Lakshmi Rajagopal at Seattle Children’s Research Institute. During his tenure at UW he published more than any other student since the Pathobiology program began in 1990. Jay received a Graduate Discovery Fellowship to work at the Centers for Disease Control from January-March, 2017 with Mary Kamb, Associate Director for Global Activities in the Division of STD Prevention.
By Lauran Neergaard
Creating new HIV prevention tools for women has proven frustratingly slow and researchers have found another hurdle: bacteria in the reproductive tract.
A new study published Thursday examined what stalled an early attempt at an anti-HIV gel, and found certain types of vaginal bacteria broke down the protective medication before it had time to work.
By Mary Engel
A Fred Hutch and University of Washington team of virologists and bioengineers led by Dr. Keith Jerome has received a $200,000 grant — the first phase of up to $1.5 million in milestone-driven funding over four years — to develop nanocarrier technology to deliver therapies to reservoirs of dormant, HIV-infected cells.
By Andrea Woo
A University of Victoria researcher says she and a colleague are close to developing a vaccine for syphilis, a disease that has reached its highest rates in B.C. in 30 years.
Microbiologist Caroline Cameron and Sheila Lukehart, a professor in the University of Washington’s department of global health, have received a nearly $3-million grant from the U.S. National Institute of Allergy and Infectious Diseases at the National Institutes of Health. The grant will help fund preclinical trials.
By Richard Watts
A University of Victoria microbiologist and her American colleague are looking for a vaccine to prevent syphilis, a venereal disease on the rise worldwide.
UVic’s Caroline Cameron, a professor of biochemistry and microbiology, is joining with University of Washington’s Sheila Lukehart, a professor of medicine and global health, to develop a vaccine to stop syphilis before it gets started in a body.
“It’s a preventive treatment, not a cure,” Cameron said.
Congratulations to Affiliate Associate Professor Joseph Smith for his work on a major malaria discovery, highlighted in this week's Association of Schools and Programs of Public Health (ASPPH) newsletter. Dr. Smith works is based in the Center for Infectious Disease Research and works with our Pathobiology program.